创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

WANG Lingbiao, CHENG Hao, LI Dan, LI Bin, LYU Ling. Advances in Biological Treatments for Systemic Lupus Erythematosus[J]. Progress in Pharmaceutical Sciences, 2018, 42(10): 744-753.
Citation: WANG Lingbiao, CHENG Hao, LI Dan, LI Bin, LYU Ling. Advances in Biological Treatments for Systemic Lupus Erythematosus[J]. Progress in Pharmaceutical Sciences, 2018, 42(10): 744-753.

Advances in Biological Treatments for Systemic Lupus Erythematosus

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a polymorphic presentation, the treatment of which is mainly based on corticosteroids and immunosuppressive agents. In recent years, biological agents for SLE continue to emerge, providing new treatment options. This article reviewed the research progress in biological treatment of SLE and made an outlook for its future development.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return